đš WEDBUSH REITERATES OUTPERFORM ON $SNDK WITH $2000 TARGET đđ
Target: 2000 đ
đ Wedbush's Matt Bryson sees the 2028 estimates as conservative, pointing to repeated buybacks and a longer product cycle â institutional confidence that often leads to repricing. đ The firm's Outperform stance with a $2000 target implies meaningful upside from current levels.
đĄ This isn't a speculative call; it's a compound thesis backed by shareholder returns and product durability. When analysts anchor to fundamentals like this, the market tends to listen â especially on a premium re-rating. đŹ Do you trust the buyback narrative enough to chase this target, or do you wait for a pullback to accumulate? đ
â ïž Not financial advice. Always manage your risk. đĄïž
đ·ïž #SNDK #Stock #Buyback #Outperform #Growth
đ„ đ
Target: 2000 đ
đ Wedbush's Matt Bryson sees the 2028 estimates as conservative, pointing to repeated buybacks and a longer product cycle â institutional confidence that often leads to repricing. đ The firm's Outperform stance with a $2000 target implies meaningful upside from current levels.
đĄ This isn't a speculative call; it's a compound thesis backed by shareholder returns and product durability. When analysts anchor to fundamentals like this, the market tends to listen â especially on a premium re-rating. đŹ Do you trust the buyback narrative enough to chase this target, or do you wait for a pullback to accumulate? đ
â ïž Not financial advice. Always manage your risk. đĄïž
đ·ïž #SNDK #Stock #Buyback #Outperform #Growth
đ„ đ